Brexpiprazole-piperazin D8
| Product Name | Brexpiprazole-piperazin D8 |
|---|---|
| Alternate Names | Brexpiprazole Stable Isotopes, Stable Isotopes of Brexpiprazole |
| CAT No. | CS-O-16168 |
| CAS No. | 1427049-21-5 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Brexpiprazole |
| Therapeutic | Anti anxiety and Anti Psychotic |
| Smileys | O=C1NC2=CC(OCCCCN3C([2H])([2H])C([2H])([2H])N(C4=C(C=CS5)C5=CC=C4)C([2H])([2H])C3([2H])[2H])=CC=C2C=C1 |
| Canonical Smiles | C1CC(CC2C1CCC(=O)N2)OCCCCN3CCN(CC3)C4=C5C=CSC5=CC=C4 |
| InchIKey | XRRHXNKGLZWHRU-DHNBGMNGSA-N |
| Inchl | InChI=1S/C25H35N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-5,10,17,19-20,22H,1-2,6-9,11-16,18H2,(H,26,29)/i12D2,13D2,14D2,15D2 |
| IUPAC | 7-[4-[4-(1-benzothiophen-4-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]butoxy]-3,4,4a,5,6,7,8,8a-octahydro-1H-quinolin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Brexpiprazole-piperazin D8 is a deuterated form of Brexpiprazole-piperazin, a medication used to treat schizophrenia and major depressive disorder. The deuterated form of the drug is used in scientific research and clinical trials to determine the drug's pharmacokinetics and metabolism.
The chemical formula of Brexpiprazole-piperazin D8 is C25H30D8N4O2, and its molecular weight is 423.62 g/mol. The drug works by blocking the activity of certain neurotransmitters in the brain, such as dopamine and serotonin, which are involved in regulating mood, emotions, and behavior.
Brexpiprazole-piperazin D8 is administered orally, usually as a tablet or capsule. The recommended dosage varies depending on the condition being treated and the patient's individual needs. It is important to follow the prescribing doctor's instructions carefully to achieve the best possible results.
Like all medications, Brexpiprazole-piperazin D8 may cause side effects, including drowsiness, dizziness, nausea, weight gain, and restlessness. It may also interact with other medications or substances, including alcohol, so it is important to inform your doctor of any other medications or supplements you are taking.
In conclusion, Brexpiprazole-piperazin D8 is an important tool in scientific research and clinical trials to better understand the pharmacology and metabolism of Brexpiprazole-piperazin. It is used to treat schizophrenia and major depressive disorder, but it should only be taken under the supervision of a licensed healthcare professional.
Get an Instant Quote
Related Compounds
Brexpiprazole D8 | DM-3411 D8 (Brexpiprazole Metabolite) |